Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran

Journal of Research in Medical Sciences

Volumn 18, Issue 3, 2013, Pages 225-229

  Hosseini, Mosalreza ^a   Amoueian, Sakineh ^b   Attaranzadeh, Armin ^c   Montazer, Mehdi ^b   Soltani, Ghodratollah ^a   Asadollahi, Khairollah ^d   Abangah, Ghobad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atrophic gastritis; Dyspepsia; Gastrin 17; Pepsinogen I; Pepsinogen II

Indexed keywords

GASTRIN 17; PEPSINOGEN I; PEPSINOGEN II;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATROPHIC GASTRITIS; BIOPSY; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84875138837     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: Epidemiology and risk factors. Arch Iran Med 2009;12:576-83.
2. st ed. New York, USA: InfoBase Publishing; 2007. p. 85-8.
3. th ed. Philadelphia: Sanduers; 2010. p. 845-8.
4. th ed. Chichester, UK: Wiley-Blackwell; 2009. p. 1005-25.
5. Valle Muñoz J, Artaza Varasa T, López Pardo R, Rodríguez Merlo R, Pérez Grueso MJ, Martín Escobedo R, et al. Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies. Gastroenterol Hepatol 2007;30:567-71.
6. th ed. Massachusetts, USA: Blackwell Science Ltd.; 2003. p. 104-131.
7. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008;43:1448-55.
8. Zhang Z, Sun L, Gong YH, Wang XG, Zhang M, Yuan Y. Factors affecting the serum gastrin 17 level: An evidence-based analysis of 3906 serum samples among Chinese. J Dig Dis 2007;8:72-6.
9. Islami F, Sheikhattari P, Ren JS, Kamangar F. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma: A systematic review and meta-analysis. Ann Oncol 2011;22:754-60.
10. Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: Comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008;6:174-9.
11. Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, PerssonEC, Islami F, et al. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: Influence of gastritis. PLoS One 2011;6:e26957.
12. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: A tutorial. Dig Liver Dis 2008;40:650-8.
13. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007;8:15-22.
14. Pimenov SI, Makarenko EV. Potentialities of a serological method in diagnosis of atrophic gastritis. Ter Arkh 2008;80:15-21.
15. Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, et al. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 2005;37:501-8.
16. Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Sasajima M, et al. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004;49:795-801.
17. Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009;15:853-9.
18. Colarossi A, Inga R, Prochazka R, Reyes U, Bussalleu A, BarúaRL. Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population. Rev Gastroenterol Peru 2011;31:110-5.
19. Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004;99:1910-5.
20. Sitas F, Smallwood R, Jewell D, Millard PR, Newell DG, Meuwissen SG, et al. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1993;2:119-23.
21. Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: An observational case-control study. Scand J Gastroenterol 2002;37:785-91.